We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$67.5M
Cap. Flow
-$16.8M
Cap. Flow %
-1.57%
Top 10 Hldgs %
43.59%
Holding
2,793
New
103
Increased
1,023
Reduced
644
Closed
145

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.03M
2
SNAP icon
Snap
SNAP
+$4.75M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$1.11M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.09M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$1.03M

Top Sells

Rank Stock Value
1
GBDC icon
Golub Capital BDC
GBDC
+$15.8M
2
NVDA icon
NVIDIA
NVDA
+$3.72M
3
COIN icon
Coinbase
COIN
+$2.93M
4
AVGO icon
Broadcom
AVGO
+$2.69M
5
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$1.89M

Sector Composition

Rank Sector Weight
1 Technology 15.66%
2 Financials 13.81%
3 Healthcare 6.79%
4 Consumer Discretionary 3.87%
5 Communication Services 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAIN icon
2026
Main Street Capital
MAIN
$5.48B
$3.77K ﹤0.01%
80
-221
-73% -$9.99K
PLTK icon
2027
Playtika
PLTK
$1.12B
$3.76K ﹤0.01%
533
+440
+473% +$3.24K
SHC icon
2028
Sotera Health
SHC
$5.38B
$3.72K ﹤0.01%
310
– –
HUN icon
2029
Huntsman Corp
HUN
$1.77B
$3.72K ﹤0.01%
143
+77
+117% +$1.91K
SAGE
2030
DELISTED
Sage Therapeutics
SAGE
$3.71K ﹤0.01%
198
– –
DCOM icon
2031
Dime Commercial Bancshares
DCOM
$1.78B
$3.7K ﹤0.01%
192
-23
-11% -$485
VITL icon
2032
Vital Farms
VITL
$525M
$3.7K ﹤0.01%
159
– –
BRZE icon
2033
Braze
BRZE
$2.99B
$3.68K ﹤0.01%
83
-12
-13% -$648
PRCT icon
2034
Procept Biorobotics
PRCT
$1.17B
$3.66K ﹤0.01%
74
– –
RLJ icon
2035
RLJ Lodging Trust
RLJ
$1.69B
$3.65K ﹤0.01%
309
-3,624
-92% -$42.6K
KAMN
2036
DELISTED
Kaman Corp
KAMN
$3.62K ﹤0.01%
79
+7
+10% +$287
RDN icon
2037
Radian Group
RDN
$4.93B
$3.62K ﹤0.01%
108
– –
CRBU icon
2038
Caribou Biosciences
CRBU
$164M
$3.61K ﹤0.01%
703
– –
DOUG icon
2039
Douglas Elliman
DOUG
$162M
$3.61K ﹤0.01%
2,285
– –
NAPA
2040
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$3.6K ﹤0.01%
387
-255
-40% -$2.33K
MERC icon
2041
Mercer International
MERC
$39.8M
$3.6K ﹤0.01%
362
– –
OPLN
2042
Openlane
OPLN
$4.54B
$3.6K ﹤0.01%
208
+104
+100% +$1.56K
ACEL icon
2043
Accel Entertainment
ACEL
$987M
$3.58K ﹤0.01%
304
-272
-47% -$2.9K
CNDT icon
2044
Conduent
CNDT
$264M
$3.58K ﹤0.01%
1,058
– –
SPB icon
2045
Spectrum Brands
SPB
$2.07B
$3.56K ﹤0.01%
40
– –
STRA icon
2046
Strategic Education
STRA
$1.92B
$3.54K ﹤0.01%
34
– –
WSFS icon
2047
WSFS Financial
WSFS
$4.15B
$3.52K ﹤0.01%
78
– –
REZI icon
2048
Resideo Technologies
REZI
$3.95B
$3.52K ﹤0.01%
157
– –
GRBK icon
2049
Green Brick Partners
GRBK
$3.14B
$3.49K ﹤0.01%
58
– –
PRTA icon
2050
Prothena Corp
PRTA
$450M
$3.49K ﹤0.01%
141
+97
+220% +$2.89K
80 81
82
83 84

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Lindbrook Capital held 2,793 positions worth $1.07B, up 6.7% from $1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Lindbrook Capital's Q1 2024 filing shows 103 new, 1,023 increased, 644 reduced and 145 closed positions. Its largest new stake was Hess Midstream: 14,335 shares worth $518K. The largest sale was Golub Capital BDC, an estimated $15.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Lindbrook Capital's largest Q1 2024 buy was Hess Midstream: 14,335 shares worth $518K.
  • Lindbrook Capital added most to Vertex Pharmaceuticals in Q1 2024, an estimated $8.03M increase.
  • Lindbrook Capital's biggest Q1 2024 reduction was Golub Capital BDC, cutting an estimated $15.8M.
  • Lindbrook Capital fully exited Splunk Inc in Q1 2024, selling an estimated $153K.
  • Lindbrook Capital's ten largest holdings make up 44% of its $1.07B portfolio in Q1 2024.
  • Lindbrook Capital opened 103 new positions and closed 145 in Q1 2024.
  • Lindbrook Capital's portfolio value rose 6.7% quarter-over-quarter to $1.07B.

Based on Lindbrook Capital's 13F filing for Q1 2024, filed 25 Apr 2024.